LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 18

Search options

  1. Article ; Online: A Mechanism of Action of Metformin in the Brain: Prevention of Methylglyoxal-Induced Glutamatergic Impairment in Acute Hippocampal Slices.

    Vizuete, Adriana Fernanda K / Fróes, Fernanda / Seady, Marina / Hansen, Fernanda / Ligabue-Braun, Rodrigo / Gonçalves, Carlos-Alberto / Souza, Diogo O

    Molecular neurobiology

    2023  

    Abstract: Metformin, a biguanide compound (N-1,1-dimethylbiguanide), is widely prescribed for diabetes mellitus type 2 (T2D) treatment. It also presents a plethora of properties, such as anti-oxidant, anti-inflammatory, anti-apoptosis, anti-tumorigenic, and anti- ... ...

    Abstract Metformin, a biguanide compound (N-1,1-dimethylbiguanide), is widely prescribed for diabetes mellitus type 2 (T2D) treatment. It also presents a plethora of properties, such as anti-oxidant, anti-inflammatory, anti-apoptosis, anti-tumorigenic, and anti-AGE formation activity. However, the precise mechanism of action of metformin in the central nervous system (CNS) needs to be clarified. Herein, we investigated the neuroprotective role of metformin in acute hippocampal slices exposed to methylglyoxal (MG), a highly reactive dicarbonyl compound and a key molecule in T2D developmental pathophysiology. Metformin protected acute hippocampal slices from MG-induced glutamatergic neurotoxicity and neuroinflammation by reducing IL-1β synthesis and secretion and RAGE protein expression. The drug also improved astrocyte function, particularly with regard to the glutamatergic system, increasing glutamate uptake. Moreover, we observed a direct effect of metformin on glutamate transporters, where the compound prevented glycation, by facilitating enzymatic phosphorylation close to Lys residues, suggesting a new neuroprotective role of metformin via PKC ζ in preventing dysfunction in glutamatergic system induced by MG. Proposed neuroprotection role of metformin in acute hippocampal slices against impairment in glutamatergic system induced in a model of methylglyoxal glycotoxicity. Metformin reversed methylglyoxal (MG)-induced neuroinflammation by reducing pro-inflammatory IL-1β synthesis and secretion and RAGE protein expression. Metformin did not alter the effect of MG on S100B secretion (1). Both MG and metformin also influenced astrocyte function in hippocampal slices. Metformin did not reverse the elevation in GLO1 activity induced by glycotoxicity; however, it abrogated the high GSH level and the expression of the co-factor of GLO1 (2). Both treatments per se changed bioenergetic metabolism and increased glucose uptake, extracellular lactate content, and pyruvate kinase (PK) activity. The increment in glucose uptake and lactate levels ceased during the co-incubation of MG with metformin. Metformin reversed the elevation of hexokinase activity by MG (3). We suggest a new role of metformin in the glutamate system, whereby it protects the hippocampus against the derangements of the glutamatergic system induced by MG, possibly by phosphorylation via PKC ζ (4). The neuroprotective action of metformin may be mediated by the phosphorylation of specific amino acid residues (Lysine) of the glutamate transporters (GLAST and GLT-1), since metformin activated the PKC ζ signaling and promoted cascades of phosphorylation in p38 MAPK and Akt proteins. The transporter protein phosphorylation prevented the Lys-glycation and the impairment of glutamate uptake induced by MG (5).
    Language English
    Publishing date 2023-11-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645020-9
    ISSN 1559-1182 ; 0893-7648
    ISSN (online) 1559-1182
    ISSN 0893-7648
    DOI 10.1007/s12035-023-03774-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Can dexamethasone prevent the seizures induced by SARS-CoV-2 infection?

    Vizuete, Adriana Fernanda K / Gonçalves, Carlos-Alberto

    Multiple sclerosis and related disorders

    2020  Volume 47, Page(s) 102606

    MeSH term(s) COVID-19/drug therapy ; Dexamethasone ; Epilepsy ; Humans ; SARS-CoV-2 ; Seizures/drug therapy
    Chemical Substances Dexamethasone (7S5I7G3JQL)
    Keywords covid19
    Language English
    Publishing date 2020-10-27
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2645330-7
    ISSN 2211-0356 ; 2211-0348
    ISSN (online) 2211-0356
    ISSN 2211-0348
    DOI 10.1016/j.msard.2020.102606
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Age-dependent effects of resveratrol in hypothalamic astrocyte cultures.

    Leite Santos, Camila / K Vizuete, Adriana Fernanda / Becker Weber, Fernanda / Thomaz, Natalie K / Bobermin, Larissa Daniele / Gonçalves, Carlos-Alberto / Quincozes-Santos, André

    Neuroreport

    2023  Volume 34, Issue 8, Page(s) 419–425

    Abstract: Objectives: The hypothalamus plays critical roles in maintaining brain homeostasis and increasing evidence has highlighted astrocytes orchestrating several of hypothalamic functions. However, it remains unclear how hypothalamic astrocytes participate in ...

    Abstract Objectives: The hypothalamus plays critical roles in maintaining brain homeostasis and increasing evidence has highlighted astrocytes orchestrating several of hypothalamic functions. However, it remains unclear how hypothalamic astrocytes participate in neurochemical mechanisms associated with aging process, as well as whether these cells can be a target for antiaging strategies. In this sense, the aim of this study is to evaluate the age-dependent effects of resveratrol, a well-characterized neuroprotective compound, in primary astrocyte cultures derived from the hypothalamus of newborn, adult, and aged rats.
    Methods: Male Wistar rats (2, 90, 180, and 365 days old) were used in this study. Cultured astrocytes from different ages were treated with 10 and 100 μM resveratrol and cellular viability, metabolic activity, astrocyte morphology, release of glial cell line-derived neurotrophic factor (GDNF), transforming growth factor β (TGF-β), tumor necrosis factor α (TNF-α), interleukins (IL-1β, IL-6, and IL-10), as well as the protein levels of Nrf2 and HO-1 were evaluated.
    Results: In vitro astrocytes derived from neonatal, adults, and aged animals changed metabolic activity and the release of trophic factors (GDNF and TGF-β), as well as the inflammatory mediators (TNF-α, IL-1β, IL-6, and IL-10). Resveratrol prevented these alterations. In addition, resveratrol changed the immunocontent of Nrf2 and HO-1. The results indicated that the effects of resveratrol seem to have a dose- and age-associated glioprotective role.
    Conclusion: These findings demonstrate for the first time that resveratrol prevents the age-dependent underlying functional reprogramming of in vitro hypothalamic astrocytes, reinforcing its antiaging activity, and consequently, its glioprotective role.
    MeSH term(s) Rats ; Animals ; Male ; Resveratrol/pharmacology ; Astrocytes/metabolism ; Rats, Wistar ; Interleukin-10/pharmacology ; Glial Cell Line-Derived Neurotrophic Factor/metabolism ; Glial Cell Line-Derived Neurotrophic Factor/pharmacology ; Tumor Necrosis Factor-alpha/metabolism ; NF-E2-Related Factor 2/metabolism ; Interleukin-6/metabolism ; Hypothalamus/metabolism ; Transforming Growth Factor beta/metabolism ; Cells, Cultured
    Chemical Substances Resveratrol (Q369O8926L) ; Interleukin-10 (130068-27-8) ; Glial Cell Line-Derived Neurotrophic Factor ; Tumor Necrosis Factor-alpha ; NF-E2-Related Factor 2 ; Interleukin-6 ; Transforming Growth Factor beta
    Language English
    Publishing date 2023-04-25
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1049746-8
    ISSN 1473-558X ; 0959-4965
    ISSN (online) 1473-558X
    ISSN 0959-4965
    DOI 10.1097/WNR.0000000000001906
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Homocysteine May Decrease Glucose Uptake and Alter the Akt/GSK3β/GLUT1 Signaling Pathway in Hippocampal Slices: Neuroprotective Effects of Rivastigmine and Ibuprofen.

    Ramires Júnior, Osmar Vieira / Silveira, Josiane Silva / Dos Santos, Tiago Marcon / Ferreira, Fernanda Silva / Vizuete, Adriana Fernanda K / Gonçalves, Carlos Alberto / Wyse, Angela T S

    Molecular neurobiology

    2023  Volume 60, Issue 9, Page(s) 5468–5481

    Abstract: ... formed, nitrite and Na+, K+-ATPase activity was increased by Hcy at 30 µM. Ibuprofen reduced ...

    Abstract Homocysteine (Hcy) is a risk factor for neurodegenerative diseases, such as Alzheimer's Disease, and is related to cellular and tissue damage. In the present study, we verified the effect of Hcy on neurochemical parameters (redox homeostasis, neuronal excitability, glucose, and lactate levels) and the Serine/Threonine kinase B (Akt), Glucose synthase kinase-3β (GSK3β) and Glucose transporter 1 (GLUT1) signaling pathway in hippocampal slices, as well as the neuroprotective effects of ibuprofen and rivastigmine alone or in combination in such effects. Male Wistar rats (90 days old) were euthanized and the brains were dissected. The hippocampus slices were pre-treated for 30 min [saline medium or Hcy (30 µM)], then the other treatments were added to the medium for another 30 min [ibuprofen, rivastigmine, or ibuprofen + rivastigmine]. The dichlorofluorescein formed, nitrite and Na+, K+-ATPase activity was increased by Hcy at 30 µM. Ibuprofen reduced dichlorofluorescein formation and attenuated the effect of Hcy. The reduced glutathione content was reduced by Hcy. Treatments with ibuprofen and Hcy + ibuprofen increased reduced glutathione. Hcy at 30 µM caused a decrease in hippocampal glucose uptake and GLUT1 expression, and an increase in Glial Fibrillary Acidic Protein-protein expression. Phosphorylated GSK3β and Akt levels were reduced by Hcy (30 µM) and co-treatment with Hcy + rivastigmine + ibuprofen reversed these effects. Hcy toxicity on glucose metabolism can promote neurological damage. The combination of treatment with rivastigmine + ibuprofen attenuated such effects, probably by regulating the Akt/GSK3β/GLUT1 signaling pathway. Reversal of Hcy cellular damage by these compounds may be a potential neuroprotective strategy for brain damage.
    MeSH term(s) Rats ; Animals ; Male ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Rivastigmine/pharmacology ; Ibuprofen/pharmacology ; Glucose Transporter Type 1/metabolism ; Rats, Wistar ; Glycogen Synthase Kinase 3 beta/metabolism ; Signal Transduction ; Hippocampus/metabolism ; Glutathione/metabolism ; Glucose/metabolism ; Homocysteine
    Chemical Substances Neuroprotective Agents ; Proto-Oncogene Proteins c-akt (EC 2.7.11.1) ; Rivastigmine (PKI06M3IW0) ; Ibuprofen (WK2XYI10QM) ; Glucose Transporter Type 1 ; Glycogen Synthase Kinase 3 beta (EC 2.7.11.1) ; Glutathione (GAN16C9B8O) ; Glucose (IY9XDZ35W2) ; Homocysteine (0LVT1QZ0BA)
    Language English
    Publishing date 2023-06-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 645020-9
    ISSN 1559-1182 ; 0893-7648
    ISSN (online) 1559-1182
    ISSN 0893-7648
    DOI 10.1007/s12035-023-03408-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Arundic acid (ONO-2506) downregulates neuroinflammation and astrocyte dysfunction after status epilepticus in young rats induced by Li-pilocarpine.

    Vizuete, Adriana Fernanda K / Leal, Miriara B / Moreira, Ana Paula / Seady, Marina / Taday, Jéssica / Gonçalves, Carlos-Alberto

    Progress in neuro-psychopharmacology & biological psychiatry

    2022  Volume 123, Page(s) 110704

    Abstract: Astrocytes, the most abundant glial cells, have several metabolic functions, including ionic, neurotransmitter and energetic homeostasis for neuronal activity. Reactive astrocytes and their dysfunction have been associated with several brain disorders, ... ...

    Abstract Astrocytes, the most abundant glial cells, have several metabolic functions, including ionic, neurotransmitter and energetic homeostasis for neuronal activity. Reactive astrocytes and their dysfunction have been associated with several brain disorders, including the epileptogenic process. Glial Fibrillary Acidic Protein (GFAP) and S100 calcium-binding protein B (S100B) are astrocyte biomarkers associated with brain injury. We hypothesize that arundic acid (ONO-2506), which is known as an inhibitor of S100B synthesis and secretion, protects the hippocampal tissue from neuroinflammation and astrocyte dysfunction after status epileptics (SE) induction by Li-pilocarpine in young rats. Herein, we investigated the effects of arundic acid treatment, at time points of 6 or 24 h after the induction of SE by Li-pilocarpine, in young rats. In SE animals, arundic acid was able to prevent the damage induced by Li-pilocarpine in the hippocampus, decreasing neuroinflammatory signaling (reducing IL-1β, COX2, TLR4 and RAGE contents), astrogliosis (decreasing GFAP and S100B) and astrocytic dysfunction (recovering levels of GSH, glutamine synthetase and connexin-43). Furthermore, arundic acid improved glucose metabolism and reduced the glutamate excitotoxicity found in epilepsy. Our data reinforce the role of astrocytes in epileptogenesis development and the neuroprotective role of arundic acid, which modulates astrocyte function and neuroinflammation in SE animals.
    MeSH term(s) Rats ; Animals ; Astrocytes/metabolism ; Pilocarpine/toxicity ; Neuroinflammatory Diseases ; Status Epilepticus/chemically induced ; Status Epilepticus/drug therapy ; Status Epilepticus/metabolism ; Epilepsy ; Hippocampus/metabolism ; Glial Fibrillary Acidic Protein/metabolism
    Chemical Substances Pilocarpine (01MI4Q9DI3) ; ONO2506 ; Glial Fibrillary Acidic Protein
    Language English
    Publishing date 2022-12-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 781181-0
    ISSN 1878-4216 ; 0278-5846
    ISSN (online) 1878-4216
    ISSN 0278-5846
    DOI 10.1016/j.pnpbp.2022.110704
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Methylglyoxal/RAGE/NOX-2 Pathway is Persistently Activated in the Hippocampus of Rats with STZ-Induced Sporadic Alzheimer's Disease.

    Moreira, Ana Paula / Vizuete, Adriana Fernanda K / Zin, Lisandra Eda Fusinato / de Marques, Charlanne Oliveira / Pacheco, Rafaela Ferreira / Leal, Miriara B / Gonçalves, Carlos-Alberto

    Neurotoxicity research

    2022  Volume 40, Issue 2, Page(s) 395–409

    Abstract: Alzheimer's disease (AD) is the leading cause of dementia in humans, with a high social and economic cost. AD is predominantly a sporadic disease, and the intracerebroventricular (ICV) administration of streptozotocin (STZ) has been widely used as an AD- ... ...

    Abstract Alzheimer's disease (AD) is the leading cause of dementia in humans, with a high social and economic cost. AD is predominantly a sporadic disease, and the intracerebroventricular (ICV) administration of streptozotocin (STZ) has been widely used as an AD-like model of dementia. While the etiology of AD remains unknown, changes such as glucose metabolism and activation of receptors for advanced glycation end products (RAGE) seem to underlie its pathogenesis. We hypothesized that methylglyoxal, an endogenous toxin derived from the glycolytic pathway, could be the precursor of advanced glycated end products that activates RAGE and that, consequently, may activate membrane NADPH oxidase (NOX), contributing to the inflammatory status of the model and the disease. We administered ICV-STZ to Wistar rats and evaluated several neurochemical parameters in the hippocampus, particularly glyoxalase 1 (GLO-1) activity, which serves as an index of high levels of methylglyoxal, and the contents of RAGE and NOX-2, the most abundant brain NOX isoform. At the times evaluated (4 and 24 weeks after STZ), we observed cognitive deficit, increased beta-amyloid content, and increased tau phosphorylation. A persistent increase in GLO-1 activity was found, as well as increases in RAGE and NOX-2 contents, suggesting astroglial and microglial commitment. The increase in NOX-2 may reflect elevated microglial activity (confirmed by IBA-1 marker), which may contribute to the synaptic dysfunction and pruning described in the literature, both in this model and AD patients. Furthermore, reinforcing this possibility, we found a reduction in cholinergic communication in the hippocampus (as shown by decreased choline acetyltransferase), a reduction in BDNF, and an increase in TGF-β, the combination of which may result in synaptic deterioration.
    MeSH term(s) Alzheimer Disease/chemically induced ; Alzheimer Disease/metabolism ; Animals ; Disease Models, Animal ; Hippocampus/metabolism ; Humans ; Maze Learning ; Pyruvaldehyde/metabolism ; Pyruvaldehyde/toxicity ; Rats ; Rats, Wistar ; Receptor for Advanced Glycation End Products/metabolism ; Streptozocin/toxicity
    Chemical Substances Receptor for Advanced Glycation End Products ; Streptozocin (5W494URQ81) ; Pyruvaldehyde (722KLD7415)
    Language English
    Publishing date 2022-02-02
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2036826-4
    ISSN 1476-3524 ; 1029-8428
    ISSN (online) 1476-3524
    ISSN 1029-8428
    DOI 10.1007/s12640-022-00476-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Astroglial Alterations in the Hippocampus of Rats Submitted to a Single Trans-Cranial Direct Current Stimulation Trial.

    Zin, Lisandra Eda Fusinato / Vizuete, Adriana Fernanda K / Callai, Etiane Micheli Meyer / Catarina, Luciana Santa / Fróes, Fernanda / Moreira, Ana Paula / de Oliveira Marques, Charlanne / Leal, Miriara B / Ponzoni, Deise / Puricelli, Edela / da Silva Torres, Iraci Lucena / Gonçalves, Carlos-Alberto / Quevedo, Alexandre Silva

    Neurochemical research

    2023  Volume 48, Issue 11, Page(s) 3447–3456

    Abstract: Evidence indicates that transcranial direct current stimulation (tDCS) provides therapeutic benefits in different situations, such as epilepsy, depression, inflammatory and neuropathic pain. Despite the increasing use of tDCS, its cellular and molecular ... ...

    Abstract Evidence indicates that transcranial direct current stimulation (tDCS) provides therapeutic benefits in different situations, such as epilepsy, depression, inflammatory and neuropathic pain. Despite the increasing use of tDCS, its cellular and molecular basis remains unknown. Astrocytes display a close functional and structural relationship with neurons and have been identified as mediators of neuroprotection in tDCS. Considering the importance of hippocampal glutamatergic neurotransmission in nociceptive pathways, we decided to investigate short-term changes in the hippocampal astrocytes of rats subjected to tDCS, evaluating specific cellular markers (GFAP and S100B), as well as markers of astroglial activity; glutamate uptake, glutamine synthesis by glutamine synthetase (GS) and glutathione content. Data clearly show that a single session of tDCS increases the pain threshold elicited by mechanical and thermal stimuli, as evaluated by von Frey and hot plate tests, respectively. These changes involve inflammatory and astroglial neurochemical changes in the hippocampus, based on specific changes in cell markers, such as S100B and GS. Alterations in S100B were also observed in the cerebrospinal fluid of tDCS animals and, most importantly, specific functional changes (increased glutamate uptake and increased GS activity) were detected in hippocampal astrocytes. These findings contribute to a better understanding of tDCS as a therapeutic strategy for nervous disorders and reinforce the importance of astrocytes as therapeutic targets.
    MeSH term(s) Rats ; Animals ; Astrocytes/metabolism ; Transcranial Direct Current Stimulation ; Hippocampus/metabolism ; Epilepsy/metabolism ; Glutamic Acid/metabolism ; Glutamate-Ammonia Ligase/metabolism
    Chemical Substances Glutamic Acid (3KX376GY7L) ; Glutamate-Ammonia Ligase (EC 6.3.1.2)
    Language English
    Publishing date 2023-07-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 199335-5
    ISSN 1573-6903 ; 0364-3190
    ISSN (online) 1573-6903
    ISSN 0364-3190
    DOI 10.1007/s11064-023-03990-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Lipopolysaccharide impairs neurodevelopment and induces changes in astroglial reactivity, antioxidant defenses and bioenergetics in the cerebral cortex of neonatal rats.

    Rojas, Denise Bertin / Vizuete, Adriana Fernanda K / de Andrade, Vivian Strassburger / de Andrade, Rodrigo Binkowski / Gemelli, Tanise / Kim, Tomas Duk Hwa / Gonçalves, Carlos Alberto / Leipnitz, Guilhian / Wannmacher, Clovis Milton Duval

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience

    2023  Volume 83, Issue 7, Page(s) 600–614

    Abstract: Neonates have an immature immune system, which increases their vulnerability to infectious agents and inflammatory insults. The administration of the immunostimulatory agent lipopolysaccharide (LPS) has been shown to induce the expression of pro- ... ...

    Abstract Neonates have an immature immune system, which increases their vulnerability to infectious agents and inflammatory insults. The administration of the immunostimulatory agent lipopolysaccharide (LPS) has been shown to induce the expression of pro-inflammatory cytokines and cause behavior alterations in rodents at different ages. However, the effects of LPS administration during the neonatal period and its consequences during immune system maturation remain to be elucidated. We showed here that a single intraperitoneal administration of LPS in rats on postnatal day (PND) 7 caused early and variable alterations in TNF-α, S100B and GFAP levels in the cerebral cortex, CSF and serum of the animals, indicating long-term induction of neuroinflammation and astroglial reactivity. However, on PND 21, only GFAP levels were increased by LPS. Additionally, LPS induced oxidative stress and altered energy metabolism enzymes in the cerebral cortex on PND 21, and caused neurodevelopment impairment over time. These data suggest that neuroinflammation induction during the neonatal period induces glial reactivity, oxidative stress and bioenergetic disruption that may lead to neurodevelopment impairment and cognitive deficit in adult life.
    MeSH term(s) Animals ; Rats ; Antioxidants/pharmacology ; Animals, Newborn ; Lipopolysaccharides/pharmacology ; Neuroinflammatory Diseases ; Cerebral Cortex ; Energy Metabolism
    Chemical Substances Antioxidants ; Lipopolysaccharides
    Language English
    Publishing date 2023-07-21
    Publishing country United States
    Document type Journal Article
    ZDB-ID 605533-3
    ISSN 1873-474X ; 0736-5748
    ISSN (online) 1873-474X
    ISSN 0736-5748
    DOI 10.1002/jdn.10288
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Early effects of LPS-induced neuroinflammation on the rat hippocampal glycolytic pathway.

    Vizuete, Adriana Fernanda K / Fróes, Fernanda / Seady, Marina / Zanotto, Caroline / Bobermin, Larissa Daniele / Roginski, Ana Cristina / Wajner, Moacir / Quincozes-Santos, André / Gonçalves, Carlos Alberto

    Journal of neuroinflammation

    2022  Volume 19, Issue 1, Page(s) 255

    Abstract: Neuroinflammation is a common feature during the development of neurological disorders and neurodegenerative diseases, where glial cells, such as microglia and astrocytes, play key roles in the activation and maintenance of inflammatory responses in the ... ...

    Abstract Neuroinflammation is a common feature during the development of neurological disorders and neurodegenerative diseases, where glial cells, such as microglia and astrocytes, play key roles in the activation and maintenance of inflammatory responses in the central nervous system. Neuroinflammation is now known to involve a neurometabolic shift, in addition to an increase in energy consumption. We used two approaches (in vivo and ex vivo) to evaluate the effects of lipopolysaccharide (LPS)-induced neuroinflammation on neurometabolic reprogramming, and on the modulation of the glycolytic pathway during the neuroinflammatory response. For this, we investigated inflammatory cytokines and receptors in the rat hippocampus, as well as markers of glial reactivity. Mitochondrial respirometry and the glycolytic pathway were evaluated by multiple parameters, including enzymatic activity, gene expression and regulation by protein kinases. Metabolic (e.g., metformin, 3PO, oxamic acid, fluorocitrate) and inflammatory (e.g., minocycline, MCC950, arundic acid) inhibitors were used in ex vivo hippocampal slices. The induction of early inflammatory changes by LPS (both in vivo and ex vivo) enhanced glycolytic parameters, such as glucose uptake, PFK1 activity and lactate release. This increased glucose consumption was independent of the energy expenditure for glutamate uptake, which was in fact diverted for the maintenance of the immune response. Accordingly, inhibitors of the glycolytic pathway and Krebs cycle reverted neuroinflammation (reducing IL-1β and S100B) and the changes in glycolytic parameters induced by LPS in acute hippocampal slices. Moreover, the inhibition of S100B, a protein predominantly synthesized and secreted by astrocytes, inhibition of microglia activation and abrogation of NLRP3 inflammasome assembly confirmed the role of neuroinflammation in the upregulation of glycolysis in the hippocampus. Our data indicate a neurometabolic glycolytic shift, induced by inflammatory activation, as well as a central and integrative role of astrocytes, and suggest that interference in the control of neurometabolism may be a promising strategy for downregulating neuroinflammation and consequently for diminishing negative neurological outcomes.
    MeSH term(s) Animals ; Cytokines/metabolism ; Glucose/metabolism ; Glutamates/metabolism ; Hippocampus/metabolism ; Inflammasomes/metabolism ; Inflammation/metabolism ; Lactates/adverse effects ; Lactates/metabolism ; Lipopolysaccharides/toxicity ; Metformin/pharmacology ; Microglia/metabolism ; Minocycline/pharmacology ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; Neuroinflammatory Diseases ; Oxamic Acid/adverse effects ; Oxamic Acid/metabolism ; Protein Kinases/metabolism ; Rats
    Chemical Substances Cytokines ; Glutamates ; Inflammasomes ; Lactates ; Lipopolysaccharides ; NLR Family, Pyrin Domain-Containing 3 Protein ; Metformin (9100L32L2N) ; Protein Kinases (EC 2.7.-) ; Minocycline (FYY3R43WGO) ; Glucose (IY9XDZ35W2) ; Oxamic Acid (QU60N5OPLG)
    Language English
    Publishing date 2022-10-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 2156455-3
    ISSN 1742-2094 ; 1742-2094
    ISSN (online) 1742-2094
    ISSN 1742-2094
    DOI 10.1186/s12974-022-02612-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top